Getinge completes acquisition of Datascope

By Jennifer Chiou

New York, Jan. 30 - Getinge AB announced the successful completion of its tender offer to acquire all outstanding shares of Datascope Corp. at a price of $53 per share in cash.

The initial offering period ended at midnight ET on Jan. 29, at which time about 96% of Datascope common stock had been validly tendered.

Immediately following its acceptance of the tendered shares, Getinge said it acquired all of the remaining Datascope shares by means of a short-form merger under Delaware law at the same price per share paid in the tender offer.

Upon completion of the merger, Datascope became an indirect wholly owned subsidiary of Getinge and will no longer be traded on the Nasdaq.

The companies previously announced jointly that they had received antitrust approval from the Federal Trade Commission for their proposed merger.

As previously reported, Datascope agreed in September to be acquired by Getinge for $865 million.

Getinge is a medical device company based in Getinge, Sweden, and Datascope is a Montvale, N.J., medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.